載入...
CART Cell Toxicities: New Insight into Mechanisms and Management
T cells genetically engineered with chimeric antigen receptors (CART) have become a potent class of cancer immunotherapeutics. Numerous clinical trials of CART cells have revealed remarkable remission rates in patients with relapsed or refractory hematologic malignancies. Despite recent clinical suc...
Na minha lista:
| 發表在: | Clin Hematol Int |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Atlantis Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785104/ https://ncbi.nlm.nih.gov/pubmed/33409484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2991/chi.k.201108.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|